ACNM Announces New President

The American College of Nuclear Medicine (ACNM) announced Gary Ulaner, MD, PhD, FACNM, as its 51st President for 2022-2023. Dr. Ulaner is the James & Pamela Muzzy Endowed Chair in Molecular Imaging and Therapy and director of Molecular Imaging and Therapy for the Hoag Family Cancer Institute, part of Hoag Memorial Hospital Presbyterian.

The official leadership transition will occur during the Virtual ACNM Annual Meeting Awards Ceremony on February 25. Dr. Ulaner was installed during a virtual event on January 29, where he said, “It is an exciting time for both clinical practice and research in molecular imaging and therapy. Together, we will work through ACNM as well as with our allies in the field to advance clinical practice, education and research in nuclear medicine. We will also continue to celebrate ACNM’s 50th anniversary throughout 2022.”

Dr. Ulaner is a nationally recognized expert in the use of targeted imaging to help direct focused cancer therapies. He leads several National Institutes of Health (NIH) clinical trials in molecular imaging and therapeutics, including two active NIH R01 grants, and has received more than $8 million in extramural funding, including generous philanthropic support from Hoag Hospital Foundation donors.

In a statement released by Hoag, Robert T. Braithwaite, president and CEO said, ““t’s an honor to congratulate Dr. Ulaner for his well-deserved role as the new ACNM president. The Hoag Family Cancer Institute is at the forefront of cancer innovation and we are proud to have a respected leader such as Dr. Ulaner continuing to advance the level of care provided to our community.”